|
Year : 2021 |
Volume: 32 |
Issue Number: 3
ORIGINAL ARTICLE
Outcomes of starting low-dose pazopanib in patients with metastatic renal cell carcinoma who do not meet eligibility criteria for clinical trials
Akatsuka Jun, Kimura Go, Obayashi Kotaro, Tsutsumi Kotaro, Yanagi Masato, Endo Yuki, Takeda Hayato, Hayashi Tatsuro, Toyama Yuka, Suzuki Yasutomo, Hamasaki Tsutomu, Yamamoto Yoichiro, Kondo Yukihiro
|
| No one has added comments on this article. Click here to add your remarks |
|
Reader
Comments